https://bsd.neuroinf.jp/w/index.php?action=history&feed=atom&title=%E3%83%86%E3%83%B3%E3%83%97%E3%83%AC%E3%83%BC%E3%83%88%3AEuphoriants
テンプレート:Euphoriants - 版の履歴
2026-04-18T12:23:38Z
このウィキのこのページに関する変更履歴
MediaWiki 1.43.8
https://bsd.neuroinf.jp/w/index.php?title=%E3%83%86%E3%83%B3%E3%83%97%E3%83%AC%E3%83%BC%E3%83%88:Euphoriants&diff=44070&oldid=prev
WikiSysop: 1版 をインポートしました
2020-07-09T07:21:17Z
<p>1版 をインポートしました</p>
<table style="background-color: #fff; color: #202122;" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="ja">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← 古い版</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">2020年7月9日 (木) 16:21時点における版</td>
</tr><tr><td colspan="4" class="diff-notice" lang="ja"><div class="mw-diff-empty">(相違点なし)</div>
</td></tr>
<!-- diff cache key wiki-mw_:diff:1.41:old-44069:rev-44070 -->
</table>
WikiSysop
https://bsd.neuroinf.jp/w/index.php?title=%E3%83%86%E3%83%B3%E3%83%97%E3%83%AC%E3%83%BC%E3%83%88:Euphoriants&diff=44069&oldid=prev
2017年9月14日 (木) 15:05にbsd>Medgirl131による
2017-09-14T15:05:43Z
<p></p>
<p><b>新規ページ</b></p><div>{{ Navbox<br />
| name = Euphoriants<br />
| title = [[Euphoriant]]s<br />
| state = {{{state<includeonly>|autocollapse</includeonly>}}}<br />
| bodyclass = hlist<br />
| list1 = <br />
<br />
* [[μ-Opioid receptor]] [[agonist]]s ([[opioid]]s) (e.g., [[morphine]], [[heroin]], [[hydrocodone]], [[oxycodone]], [[opium]], [[kratom]])<br />
* [[Voltage-dependent calcium channel#.CE.B12.CE.B4 Subunit|α<sub>2</sub>δ subunit]]-containing [[voltage-dependent calcium channel]]s [[calcium channel blocker|blocker]]s ([[gabapentinoid]]s) (e.g., [[gabapentin]], [[pregabalin]], [[phenibut]])<br />
* [[AMPA receptor]] [[receptor antagonist|antagonist]]s (e.g., [[perampanel]])<br />
* [[CB1 receptor|CB<sub>1</sub> receptor]] [[agonist]]s ([[cannabinoid]]s) (e.g., [[tetrahydrocannabinol|THC]], [[cannabis (drug)|cannabis]])<br />
* [[Dopamine agonist|Dopamine receptor agonist]]s (e.g., [[levodopa]])<br />
* [[Dopamine releasing agent]]s (e.g., [[amphetamine]], [[methamphetamine]], [[MDMA]], [[mephedrone]])<br />
* [[Dopamine reuptake inhibitor]]s (e.g., [[cocaine]], [[methylphenidate]])<br />
* [[GABAA receptor|GABA<sub>A</sub> receptor]] [[positive allosteric modulator]]s (e.g., [[barbiturate]]s, [[benzodiazepine]]s, [[carbamate]]s, [[alcohol (drug)|ethanol (alcohol)]] ([[alcoholic drink]]), [[inhalant]]s, [[nonbenzodiazepine]]s, [[quinazolinone]]s)<br />
* [[gamma-Hydroxybutyric acid|GHB]] ([[sodium oxybate]]) and [[structural analog|analogue]]s<br />
* [[Glucocorticoid|Glucocorticoids (corticosteroids)]] (e.g., [[dexamethasone]], [[prednisone]])<br />
* [[Nicotinic agonist|nACh receptor agonist]]s (e.g., [[nicotine]], [[tobacco]], [[arecoline]], [[areca nut]])<br />
* [[Nitric oxide donor|Nitric oxide prodrug]]s (e.g., [[alkyl nitrite]]s ([[poppers]]))<br />
* [[NMDA receptor antagonist]]s (e.g., [[dextromethorphan|DXM]], [[ketamine]], [[methoxetamine]], [[nitrous oxide]], [[phencyclidine]], [[inhalant]]s)<br />
* [[Orexin antagonist|Orexin receptor antagonist]]s (e.g., [[suvorexant]])<br />
<br />
| below = '''''See also:''' [[Template:Drug use|Recreational drug use]]''<br />
<br />
}}<noinclude><br />
{{collapsible option}}<br />
[[Category:Drug templates]]<br />
</noinclude></div>
bsd>Medgirl131